These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 30972074)

  • 1. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
    Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
    Front Immunol; 2018; 9():362. PubMed ID: 29545797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
    Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
    Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
    Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
    J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
    Bamias G; Jia LG; Cominelli F
    Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
    Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
    Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
    Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
    Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation.
    Meylan F; Song YJ; Fuss I; Villarreal S; Kahle E; Malm IJ; Acharya K; Ramos HL; Lo L; Mentink-Kane MM; Wynn TA; Migone TS; Strober W; Siegel RM
    Mucosal Immunol; 2011 Mar; 4(2):172-85. PubMed ID: 20980995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
    Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
    Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Levels of Tl1a Affect the Expansion and Function of Regulatory T Cells in Modulating Murine Colitis.
    Sidhu-Varma M; Shih DQ; Targan SR
    Inflamm Bowel Dis; 2016 Mar; 22(3):548-59. PubMed ID: 26818423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble TL1A is sufficient for activation of death receptor 3.
    Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M
    FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
    Aiba Y; Nakamura M
    Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
    Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
    Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
    Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
    Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.